Abstract
We report a 72-year-old man with Waldenström's macroglobulinemia (WM) in whom diffuse large B-cell lymphoma (DLCL) occurred 17 years after the diagnosis of WM. The malignant cells of both DLCL and WM expressed CD20 on their surface. CHOP plus anti-CD20 monoclonal antibody, rituximab, were effective for both diseases, and the patient remains disease-free 17 months later.
Original language | English |
---|---|
Pages (from-to) | 131-134 |
Number of pages | 4 |
Journal | Internal Medicine |
Volume | 43 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 1 2004 |
All Science Journal Classification (ASJC) codes
- Internal Medicine